Semax vs Selank
A side-by-side research reference for Semax and Selank — mechanism of action, catalogue data, and the key studies behind each compound.
| Comparison | ||
|---|---|---|
| Compound class | Peptides · Injectable vial | Peptides · Injectable vial |
| Mechanism of action | ACTH(4-10)-derived heptapeptide that upregulates BDNF and NGF, modulates dopaminergic and serotonergic signalling, and reduces neuroinflammation markers. | Tuftsin analogue extended with Pro-Gly-Pro that modulates GABA-A receptor expression, inhibits enkephalinase, and upregulates serotonin synthesis without sedation. |
| Reference concentration | 10mg | 10mg |
| Research form | Injectable vial | Injectable vial |
Key studies on Semax
More comparisons
Research Use Only
All compounds referenced on this page are sold for in vitro laboratory research use only. Not for human consumption, medical use, or self-administration. Not evaluated by the FDA. This page is for research and informational purposes only.

